NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Recs

0
Player Avatar pedromigz (26.30) Submitted: 9/14/2009 12:54:03 PM : Outperform Start Price: $41.99 NUVA Score: -81.23

pt47, z1

Report this Post Reply

Featured Broker Partners


Advertisement